Bayer Announces the Launch of Aleve® Direct Therapy™ TENS Device to Help People who Suffer from Lower Back Pain

Aleve Direct Therapy is Powered by the Same TENS Technology Used By Doctors

News provided by

Jul 14, 2016, 08:03 ET

WHIPPANY, N.J., July 14, 2016 /PRNewswire/ -- Today, Bayer announced that Aleve® Direct Therapy™, a safe, drug-free, pain relief device, is now available at retailers nationwide in the analgesics aisle. Aleve Direct Therapy uses the same TENS (Transcutaneous Electrical Nerve Stimulation) technology used by doctors to provide consumers with deep penetrating relief at the source of lower back pain. TENS is a non-invasive, drug-free method of controlling pain that works by delivering stimulating pulses at the site of pain.

"For people suffering from lower back pain the availability of the Aleve Direct Therapy TENS Device is good news. The device provides drug-free, deep penetrating lower-back pain relief, without a prescription," said Fred Duchin, Vice President of Marketing Analgesics of Cough & Cold, Cardiovascular, Consumer Health Division.

Aleve Direct Therapy is indicated for the temporary relief of pain associated with sore and aching muscles in the lower back due to strain from exercise or normal household and work activities. Aleve Direct Therapy is regulated as a Class II medical device and was cleared by the U.S. Food and Drug Administration. Its unique patented waveform technology can provide deep penetrating relief by blocking the body's pain signals and by releasing endorphins in the areas of pain – the two theories behind how TENS technology works.

"Aleve Direct Therapy puts controllable TENS technology in consumers hands without having to visit the doctor. It provides high intensity of power and its wireless remote control makes it easy to adjust the power of intensity to fit the user's needs," said Andre Schmidt, Vice President, US Medical Affairs, Consumer Health Division. "We are pleased to be able to provide this safe, drug-free and convenient self-care option to help consumers get the relief they need from lower back pain."

For more information about Aleve Direct Therapy, please visit: https://www.aleve.com/aleve-direct-therapy/

For Aleve Direct Therapy FAQ's, please visit: https://www.aleve.com/aleve-direct-therapy/aleve-direct-therapy-faq/

About Aleve Direct Therapy
Aleve Direct Therapy is a high quality, durable device that provides a high level of stimulation intensity. The patented design, wireless remote control and waveform technology provides a unique treatment.The patented waveform technology was designed to incorporate two clinical theories of how TENS provides pain relief: by blocking the transmission of pain and stimulating endorphins, the body's natural pain reducing chemicals. Aleve Direct Therapy can be worn discretely and comfortably throughout the day on the user's lower back, even during some physical activities – at home, work or on the go.

Bayer: Science For A Better Life

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.us.

Forward-Looking Statements

This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Logo - http://photos.prnewswire.com/prnh/20140312/NY79226LOGO

SOURCE Bayer